Haemonetics
HAE
HAE
307 hedge funds and large institutions have $4.42B invested in Haemonetics in 2024 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 124 increasing their positions, 88 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
2% more call options, than puts
Call options by funds: $42.5M | Put options by funds: $41.7M
1% more funds holding
Funds holding: 304 → 307 (+3)
1% less capital invested
Capital invested by funds: $4.45B → $4.42B (-$31.4M)
Holders
307
Holding in Top 10
4
Calls
$42.5M
Puts
$41.7M
Top Buyers
| 1 | +$30.6M | |
| 2 | +$22.1M | |
| 3 | +$19.9M | |
| 4 |
SCM
SG Capital Management
Chicago,
Illinois
|
+$18.4M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$13.2M |
Top Sellers
| 1 | -$33.4M | |
| 2 | -$23.2M | |
| 3 | -$20.4M | |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
-$15.9M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$11.9M |